GILOTRIF Reviews (AFATINIB DIMALEATE)

Average Rating: 4.0 (1 Ratings)

Filter Results

Compare GILOTRIF with similar:

 Type: Rx Drug

  

GILOTRIF  (AFATINIB DIMALEATE):  Afatinib is used to treat a certain type of lung cancer (non-small cell lung cancer) that has spread to other parts of the body. It belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.   FDA Approval Date: 2013-07-12 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


  Charts & graphs: Drug Safety Information

RATING  REASONSIDE EFFECTS FOR GILOTRIFCOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 4  NSCLC M 40 6 months
40 mg		 11/15/2015
  

GILOTRIF  (AFATINIB DIMALEATE):  Afatinib is used to treat a certain type of lung cancer (non-small cell lung cancer) that has spread to other parts of the body. It belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.   FDA Approval Date: 2013-07-12 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP